Survival following lung transplantation for artificial stone silicosis relative to idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Survival following lung transplantation for artificial stone silicosis relative to idiopathic pulmonary fibrosis

Published:2017-02-01 Issue:3 Volume:60 Page:248-254
ISSN:0271-3586
Container-title:American Journal of Industrial Medicine
language:en
Short-container-title:Am. J. Ind. Med.

Author:

Rosengarten Dror¹²,Fox Benjamin D.¹²,Fireman Elizabeth²³,Blanc Paul D.⁴,Rusanov Victoria¹²,Fruchter Oren¹²,Raviv Yael¹²,Shtraichman Osnat¹²,Saute Milton²⁵,Kramer Mordechai R.¹²

Affiliation:

1. Institute of Pulmonology; Rabin Medical Center; Beilinson Campus; Petah Tiqwa Israel

2. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

3. The Institute of Pulmonary and Allergic Diseases; Tel-Aviv Sourasky Medical Center; Tel-Aviv Israel

4. Division of Occupational and Environmental Medicine; Department of Medicine and Cardiovascular Research Institute; University of California; San Francisco California

5. Department of Cardiothoracic Surgery; Rabin Medical Center; Beilinson Campus; Petah Tiqwa Israel

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health

Reference28 articles.

1. Idiopathic pulmonary fibrosis: Diagnosis and treatment. international consensus statement. american thoracic society (ATS), the european respiratory society (ERS);Am J Respir Crit Care Med,2000

2. Systemic inhibition of nf-kappab activation protects from silicosis;Di Giuseppe;PLoS ONE,2009

3. Survival after lung transplant for coal workers’ pneumoconiosis;Enfield;J Heart Lung Transplant,2012

4. Complicated silicosis in an Australian worker from cutting engineered stone countertops: An embarrassing first for Australia;Frankel;Respirology,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation;Frontiers in Immunology;2024-02-06

2. Silico-tuberculosis amidst COVID-19 pandemic: global scenario and Indian perspective;Annals of Medicine & Surgery;2023-11-01

3. Human embryonic stem cell‐derived mesenchymal stem cell secretome reverts silica‐induced airway epithelial cell injury by regulating Bmi1 signaling;Environmental Toxicology;2023-05-25

4. Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease;Frontiers in Bioscience-Landmark;2023-05-22

5. From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis;International Journal of Molecular Sciences;2023-05-05